Literatura científica selecionada sobre o tema "Atypical Chemokine Receptors"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Atypical Chemokine Receptors".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Atypical Chemokine Receptors"
Hansell, C. A. H., C. V. Simpson e R. J. B. Nibbs. "Chemokine sequestration by atypical chemokine receptors". Biochemical Society Transactions 34, n.º 6 (25 de outubro de 2006): 1009–13. http://dx.doi.org/10.1042/bst0341009.
Texto completo da fonteBorroni, Elena M., Raffaella Bonecchi e Annalisa M. VanHook. "Science Signaling Podcast: 30 April 2013". Science Signaling 6, n.º 273 (30 de abril de 2013): pc11. http://dx.doi.org/10.1126/scisignal.2004231.
Texto completo da fonteGroblewska, Magdalena, Ala Litman-Zawadzka e Barbara Mroczko. "The Role of Selected Chemokines and Their Receptors in the Development of Gliomas". International Journal of Molecular Sciences 21, n.º 10 (24 de maio de 2020): 3704. http://dx.doi.org/10.3390/ijms21103704.
Texto completo da fonteUlvmar, Maria Helena, Elin Hub e Antal Rot. "Atypical chemokine receptors". Experimental Cell Research 317, n.º 5 (março de 2011): 556–68. http://dx.doi.org/10.1016/j.yexcr.2011.01.012.
Texto completo da fonteGencer, Selin, Emiel van der Vorst, Maria Aslani, Christian Weber, Yvonne Döring e Johan Duchene. "Atypical Chemokine Receptors in Cardiovascular Disease". Thrombosis and Haemostasis 119, n.º 04 (4 de fevereiro de 2019): 534–41. http://dx.doi.org/10.1055/s-0038-1676988.
Texto completo da fonteLegler, Daniel F., e Marcus Thelen. "New insights in chemokine signaling". F1000Research 7 (23 de janeiro de 2018): 95. http://dx.doi.org/10.12688/f1000research.13130.1.
Texto completo da fonteGustavsson, Martin, Douglas P. Dyer, Chunxia Zhao e Tracy M. Handel. "Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding". Science Signaling 12, n.º 598 (10 de setembro de 2019): eaaw3657. http://dx.doi.org/10.1126/scisignal.aaw3657.
Texto completo da fontePacheco, Messias Oliveira, Fernanda Agostini Rocha, Thiago Pinheiro Arrais Aloia e Luciana Cavalheiro Marti. "Evaluation of Atypical Chemokine Receptor Expression in T Cell Subsets". Cells 11, n.º 24 (16 de dezembro de 2022): 4099. http://dx.doi.org/10.3390/cells11244099.
Texto completo da fonteMiyabe, Yoshishige, Chie Miyabe, Vinidhra Mani, Thorsten R. Mempel e Andrew D. Luster. "Atypical complement receptor C5aR2 transports C5a to initiate neutrophil adhesion and inflammation". Science Immunology 4, n.º 35 (10 de maio de 2019): eaav5951. http://dx.doi.org/10.1126/sciimmunol.aav5951.
Texto completo da fonteLeick, Marion, Julie Catusse e Meike Burger. "The Atypical Chemokine Receptor CRAM Mediates CCL19 Transcytosis through Endothelial Cells and Modulates CCL19 Activation of Non-Hodgkin Lymphoma B Cells." Blood 114, n.º 22 (20 de novembro de 2009): 2672. http://dx.doi.org/10.1182/blood.v114.22.2672.2672.
Texto completo da fonteTeses / dissertações sobre o assunto "Atypical Chemokine Receptors"
Tiplady, Eleanor Margaret. "Expression and modulation of atypical chemokine receptors on epithelial cells". Thesis, University of Glasgow, 2018. http://theses.gla.ac.uk/30618/.
Texto completo da fonteBenoit, Alice. "Identification du rôle de l’hypoxie dépendante de HIF-1α dans la régulation de l’expression de ACKR2 (Atypical Chemokine Receptor 2) dans le cancer". Electronic Thesis or Diss., Université de Lorraine, 2024. http://www.theses.fr/2024LORR0051.
Texto completo da fonteAnti-cancer therapies, particularly immunotherapy, have made considerable progress in recent years; however, only a small number of patients derive significant and lasting clinical benefit. The incapacity of cytotoxic immune cells to infiltrate the tumor microenvironment explains in part this phenomenon. Immune infiltration depends in particular on the chemokine network, regulated in part by ACKRs. The aim of this thesis was to study the mechanisms involved in the regulation of ACKR2, which regulates the pro inflammatory chemokine network. In silico data showed that both murine and human ACKR2 promoters contain hypoxia response elements. In vitro, hypoxic colorectal, melanoma and breast cancer cells overexpressed ACKR2, which was no longer the case for cells with a deletion of HIF-1α. In vivo, ACKR2 expression was also decreased in HIF-1α-deleted tumors and associated with increased CCL5 and immune infiltration. Chromatin immunoprecipitation showed HIF-1α directly binds onto the HRE motifs of ACKR2 promoter in melanoma cells
Yu, Tian. "Role of atypical chemokine receptor-2 in ocular inflammation". Thesis, University of Aberdeen, 2015. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=229021.
Texto completo da fonteHurson, Catherine Eileen. "Expression and function of the atypical chemokine receptor CCX-CKR". Thesis, University of Glasgow, 2011. http://theses.gla.ac.uk/2718/.
Texto completo da fonteKing, Vicky. "Assessment of the therapeutic potential of the atypical chemokine receptor, D6". Thesis, University of Glasgow, 2010. http://theses.gla.ac.uk/2165/.
Texto completo da fonteTeoh, Pek Joo. "The role of the atypical chemokine receptor D6 in the placenta". Thesis, University of Glasgow, 2014. http://theses.gla.ac.uk/5098/.
Texto completo da fonteLucas, Beth. "Expression and function of the atypical chemokine receptor CCRL1 in the thymus". Thesis, University of Birmingham, 2015. http://etheses.bham.ac.uk//id/eprint/5971/.
Texto completo da fonteVacchini, A. "ANALYSIS OF BIASED SIGNALING IN THE CHEMOKINE SYSTEM". Doctoral thesis, Università degli Studi di Milano, 2016. http://hdl.handle.net/2434/365864.
Texto completo da fonteShams, Kave. "The role and regulation of the atypical chemokine receptor 2 in psoriasiform inflammation". Thesis, University of Glasgow, 2017. http://theses.gla.ac.uk/8121/.
Texto completo da fonteKorniejewska, Anna. "Characterisation of the chemokine receptor CXCR3 and its atypical variants in human T lymphocytes". Thesis, University of Bath, 2009. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.518106.
Texto completo da fonteLivros sobre o assunto "Atypical Chemokine Receptors"
Hughes, Jeremy. Proteinuria as a direct cause of progression. Editado por David J. Goldsmith. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0137.
Texto completo da fonteCapítulos de livros sobre o assunto "Atypical Chemokine Receptors"
Singh, Mark D., Robert J. B. Nibbs e Gerard J. Graham. "The Atypical Chemokine Receptors". In Methods and Principles in Medicinal Chemistry, 67–83. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2011. http://dx.doi.org/10.1002/9783527631995.ch4.
Texto completo da fonteBonecchi, Raffaella, Matteo Massara e Massimo Locati. "Atypical Chemokine Receptors". In Encyclopedia of Immunobiology, 579–85. Elsevier, 2016. http://dx.doi.org/10.1016/b978-0-12-374279-7.10009-8.
Texto completo da fonteWerth, Kathrin, e Reinhold Förster. "Active Shaping of Chemokine Gradients by Atypical Chemokine Receptors". In Methods in Enzymology, 293–308. Elsevier, 2016. http://dx.doi.org/10.1016/bs.mie.2015.09.008.
Texto completo da fonteBorroni, Elena, Cinzia Cancellieri, Massimo Locati e Raffaella Bonecchi. "Dissecting Trafficking and Signaling of Atypical Chemokine Receptors". In Methods in Enzymology, 151–68. Elsevier, 2013. http://dx.doi.org/10.1016/b978-0-12-391862-8.00008-9.
Texto completo da fonteLokeshwar, Bal L., Georgios Kallifatidis e James J. Hoy. "Atypical chemokine receptors in tumor cell growth and metastasis". In Advances in Cancer Research, 1–27. Elsevier, 2020. http://dx.doi.org/10.1016/bs.acr.2019.12.002.
Texto completo da fonteLuís, Rafael, Giulia D’Uonnolo, Christie B. Palmer, Max Meyrath, Tomasz Uchański, May Wantz, Bernard Rogister, Bassam Janji, Andy Chevigné e Martyna Szpakowska. "Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors". In Methods in Cell Biology. Elsevier, 2022. http://dx.doi.org/10.1016/bs.mcb.2022.03.002.
Texto completo da fonteSjöberg, Elin, Max Meyrath, Andy Chevigné, Arne Östman, Martin Augsten e Martyna Szpakowska. "The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy". In Advances in Cancer Research, 99–138. Elsevier, 2020. http://dx.doi.org/10.1016/bs.acr.2019.12.001.
Texto completo da fonteKleist, Andrew B., Francis Peterson, Robert C. Tyler, Martin Gustavsson, Tracy M. Handel e Brian F. Volkman. "Solution NMR spectroscopy of GPCRs: Residue-specific labeling strategies with a focus on 13C-methyl methionine labeling of the atypical chemokine receptor ACKR3". In Methods in Cell Biology, 259–88. Elsevier, 2019. http://dx.doi.org/10.1016/bs.mcb.2018.09.004.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Atypical Chemokine Receptors"
Jenkins, Brittany D., Rupali Hire, Elizabeth Howerth, Michele Monteil, Rachel Martini e Melissa B. Davis. "Abstract 953: Atypical chemokine receptor 1 (ACKR1/DARC) expressing tumors are associated with distinct recruitment of immune cells and increased pro-inflammatory chemokines". In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-953.
Texto completo da fonteJenkins, Brittany D., Rachel N. Martini, Rupali Hire, Michele A. Monteil e Melissa B. Davis. "Abstract B39: Distinct recruitment of tumor-associated immune cells correlates with increased pro-malignant chemokines in tumors expressing epithelial Atypical Chemokine Receptor 1 (ACKR1/DARC)". In Abstracts: Ninth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; September 25-28, 2016; Fort Lauderdale, FL. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7755.disp16-b39.
Texto completo da fonteSalazar, Nicole, Daniel Muñoz e Bal L. Lokeshwar. "Abstract C210: Atypical chemokine receptor 3/CXCR7 and EGFR interact to control breast cancer growth." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-c210.
Texto completo da fonteJenkins, Brittany D., Rachel N. Martini, Inasia Brown e Melissa B. Davis. "Abstract 5071: The functional relevance of Atypical Chemokine Receptor 1 (ACKR1/DARC) genetic isoforms in breast cancer". In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-5071.
Texto completo da fonteJenkins, Brittany D., Rachel Martini, Kevin Gardner, Michele Monteil, Dorrah Deeb, Lisa Newman e Melissa Davis. "Abstract 4565: The functional role of atypical chemokine receptor 1 in immune cell regulation of breast cancer". In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-4565.
Texto completo da fonteJenkins, Brittany D., Rachel Martini, Kevin Gardner, Michele Monteil, Dorrah Deeb, Lisa Newman e Melissa Davis. "Abstract 4565: The functional role of atypical chemokine receptor 1 in immune cell regulation of breast cancer". In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-4565.
Texto completo da fonteKim, Nayoung, Seung-Woo Baek, Hyewon Ryu, Yoon Seok Choi, Ik Chan Song, Hwan Jung Yun, Deog Yeon Jo, Samyong Kim e Hyo Jin Lee. "Abstract 3947: Atypical chemokine receptor ACKR3 expression is associated with aggressive behavior and poor prognosis in gastric cancer". In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-3947.
Texto completo da fonteJenkins, BD, RN Martini, R. Hire, MA Monteil e MB Davis. "Abstract P6-01-11: Distinct recruitment of tumor-associated immune cells correlates with increased pro-malignant chemokines in tumors expressing epithelial atypical chemokine receptor 1 (ACKR1/DARC), indicating a unique tumor microenvironment". In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-p6-01-11.
Texto completo da fonte